Literature DB >> 856029

Mutagenicity and antibacterial activity of hydroxamic acids.

C Y Wang, L H Lee.   

Abstract

Hydroxamic acids demonstrated mutagenic and antibacterial activities. These activities appear to be dependent on the hydroxamic acid function and are probably due to the interaction with deoxyribonucleic acid.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 856029      PMCID： PMC352062          DOI： 10.1128/AAC.11.4.753

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  Antifungal activity of decanoic hydroxamic acid.

Authors:  G R GALE; F BERNHEIM; A M WELCH
Journal:  Proc Soc Exp Biol Med       Date:  1962-01

2.  Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids.

Authors:  J McCann; N E Spingarn; J Kobori; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

3.  Salicylhydroxamic acid as an antitubercular agent.

Authors:  T URBANSKI
Journal:  Nature       Date:  1950-08-12       Impact factor: 49.962

4.  Sorbic Hydroxamic Acid, an Antifungal Agent Effective over a Wide pH Range.

Authors:  W F Dudman
Journal:  Appl Microbiol       Date:  1963-07

5.  Prevention of infected urinary stones by urease inhibition.

Authors:  D P Griffith; D M Musher
Journal:  Invest Urol       Date:  1973-11

6.  Antimicrobial activity of hydroxamic acids.

Authors:  J Hase; K Kobashi; N Kawaguchi; K Sakamoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1971-02       Impact factor: 1.645

7.  Effect of acyl residues of hydroxamic acids on urease inhibition.

Authors:  K Kobashi; K Kumaki; J I Hase
Journal:  Biochim Biophys Acta       Date:  1971-02-10
  7 in total
  3 in total

1.  Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget?

Authors:  Sida Shen; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2015-11-25       Impact factor: 3.466

2.  Hydroxamic acid - A novel molecule for anticancer therapy.

Authors:  Dilipkumar Pal; Supriyo Saha
Journal:  J Adv Pharm Technol Res       Date:  2012-04

3.  Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis.

Authors:  Aditi Gupta; Wei Cao; Meenakshi A Chellaiah
Journal:  Mol Cancer       Date:  2012-09-11       Impact factor: 27.401
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.